Evaluation of immuno modulator effect with lymphopaenia and other side effects in relapsingremitting multiple sclerosis patients using fingolimod: clinical data preliminary results
been licensed in many countries worldwide. Fingolimod is an oral sphingosine-1-phosphate-receptor modulator which reduces the recirculation of immune cells and may also directly target glial cells. Fingolimod…

